Neuroleptic intolerance in patients with anti-NMDAR encephalitis (Q37216597)

19 August 2017

Neuroleptic intolerance in patients with anti-NMDAR encephalitis (English)

1 reference

19 August 2017

Florian Lejuste

1

0 references

Veronique Rogemond

object named as

Veronique Rogemond

6

0 references

Marion Leboyer

object named as

Marion Leboyer

11

0 references

François Ducray

5

object named as

François Ducray

1 reference

19 August 2017

10

Laurent Groc

1 reference

19 August 2017

Laure Thomas

2

1 reference

19 August 2017

Géraldine Picard

3

1 reference

19 August 2017

Virginie Desestret

4

1 reference

19 August 2017

Dimitri Psimaras

7

1 reference

19 August 2017

Jean-Christophe Antoine

8

1 reference

19 August 2017

Jean-Yves Delattre

9

1 reference

19 August 2017

Jerome Honnorat

12

1 reference

19 August 2017

29 August 2016

1 reference

Neurology(R) neuroimmunology & neuroinflammation

19 August 2017

1 reference

19 August 2017

3

1 reference

19 August 2017

e280

1 reference

19 August 2017

5

1 reference

Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Anti-NMDA Receptor Encephalitis in Psychiatry

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

The emerging link between autoimmune disorders and neuropsychiatric disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Disease-relevant autoantibodies in first episode schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Risk of neuroleptic malignant syndrome in patients with NMDAR encephalitis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Late onset autism and anti-NMDA-receptor encephalitis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5004531

Antipsychotic-induced akathisia and neuroleptic malignant syndrome in anti-NMDAR encephalitis

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27606355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Amantadine and the glutamate hypothesis of schizophrenia Experiences in the treatment of neuroleptic malignant syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27606355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The universal field hypothesis of catatonia and neuroleptic malignant syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27606355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/NXI.0000000000000280

1 reference

19 August 2017

1 reference

19 August 2017

1 reference